News Releases
This section contains information and press releases about Boston Scientific. Press releases are listed in chronological order and archived by year. Information should be considered accurate as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Boston Scientific is not obligated to update the press releases and information contained in this section of the website.
Click here to access archived Guidant press releases.
Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004
2004 Archives
Dec 31, 2004 and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and for the year ended December 31, 2004 at a meeting with... |
|
Dec 30, 2004 (December 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is donating $100,000 to the Red Cross for tsunami relief. The money is being directed to the Red Cross'... |
|
Dec 20, 2004 (December 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced an expansion of its management structure designed to position the Company for continued growth and success. The... |
|
Dec 16, 2004 (December 16, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into a definitive agreement to acquire Advanced Stent Technologies, Inc. (AST) of Pleasanton,... |
|
Dec 2, 2004 (December 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today commented on a ruling by the U.S. District Court for the Southern District of New York on preliminary motions in a breach of... |
|
Nov 29, 2004 (November 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Intravascular Ultrasound (IVUS) procedures have been recognized for payment under a new Medicare... |
|
Nov 24, 2004 (November 24, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lazard Frères First Annual Life Sciences Conference, which will take place November 30 and... |
|
Nov 23, 2004 (November 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it had exercised its right under an existing licensing agreement with Angiotech Pharmaceuticals, Inc. (NASDAQ:... |
|
Nov 22, 2004 (November 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the French government that it has added new categories of "high-risk" patients to the... |
|
Nov 18, 2004 (November 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its public offering of $250 million aggregate principal amount of its 4.250 percent senior notes... |
|
Nov 16, 2004 (November 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has made an equity investment in -- and secured an exclusive option to purchase -- REVA Medical, Inc., a... |
|
Nov 15, 2004 (November 15, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today the launch of a public offering of two series of its senior notes under the Company's existing shelf registration... |
|
Nov 12, 2004 (November 12, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Credit Suisse First Boston Healthcare Conference 2004, which is being held November 17-19 in... |
|
Nov 8, 2004 (November 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Valencia, California, is resuming worldwide distribution of its... |
|
Nov 5, 2004 (November 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its TAXUS™ Express2™ paclitaxel-eluting coronary stent system will be the subject of 15 presentations at... |
|
Nov 4, 2004 (November 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Fifteenth Annual Healthcare Conference, which is being held November 8-10 in... |
|
Nov 2, 2004 and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced interim results from a 200-patient clinical trial to evaluate the effectiveness, safety and... |
|
Nov 2, 2004 and Orlando, FL (November 2, 2004)-- Boston Scientific Corporation (NYSE: BSX) today announced results supporting the efficacy of the Enteryx Procedure in relieving the symptoms of... |
|
Nov 2, 2004 and Orlando, FL (November 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its ongoing Enteryx Procedure clinical trial for the treatment of... |
|
Nov 1, 2004 (November 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the National Institute for Clinical... |
|
Oct 28, 2004 (October 28, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has launched a full line of mid-urethral sling products for the treatment of female stress urinary... |
|
Oct 27, 2004 (October 27, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE 2 registry program, which plans to enroll 5,000 patients at approximately 60... |
|
Oct 26, 2004 (October 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Board of Directors has authorized the repurchase of up to 50 million shares of the Company's common stock... |
|
Oct 19, 2004 (October 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2004. Highlights: Net sales of $1.482 billion, an... |
|
Oct 13, 2004 (October 13, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary... |
|
1-25 26-50 51-75 76-99 | |